When it comes to clinical trials, doing things the way they’ve always been done has negative impacts on what matters most — the patient journey.

We need a new paradigm to accelerate clinical trials and give better outcomes for patients.

And leading the charge for this new paradigm is today’s guest, Len Rosenberg, Head of Clinical Operations at Beat AML, a division of The Leukemia & Lymphoma Society. He joins the show to share his successes in this groundbreaking new trial that’s delivering better outcomes for patients.

In this episode, we discuss:

- How Beat AML’s innovative approach has led to better patient outcomes

- How regulations, audits and conventional wisdom can distract from the core aims of clinical research

- The importance of early signals and failing fast

To hear more from Accelerating Clinical, check us out on Apple Podcasts, Spotify, or on our website.

Listening on a desktop & can’t see the links? Just search for Accelerating Clinical on your favorite podcast player.